OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout
Binita Shah, Michael Toprover, Daria B. Crittenden, et al.
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 11, pp. 1722-1728
Open Access | Times Cited: 25
Binita Shah, Michael Toprover, Daria B. Crittenden, et al.
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 11, pp. 1722-1728
Open Access | Times Cited: 25
Showing 25 citing articles:
Colchicine in Cardiovascular Disease: In-Depth Review.
Spyridon Deftereos, Frans Beerkens, Binita Shah, et al.
PubMed (2022) Vol. 145, Iss. 1, pp. 61-78
Closed Access | Times Cited: 166
Spyridon Deftereos, Frans Beerkens, Binita Shah, et al.
PubMed (2022) Vol. 145, Iss. 1, pp. 61-78
Closed Access | Times Cited: 166
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
Aaron Reyes, Kelly A Hu, Jacob Teperman, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 5, pp. 550-557
Open Access | Times Cited: 140
Aaron Reyes, Kelly A Hu, Jacob Teperman, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 5, pp. 550-557
Open Access | Times Cited: 140
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease
Kyle A. Nelson, Valentı́n Fuster, Paul M. Ridker
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. 648-660
Closed Access | Times Cited: 106
Kyle A. Nelson, Valentı́n Fuster, Paul M. Ridker
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. 648-660
Closed Access | Times Cited: 106
Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Michelle Samuel, Jean‐Claude Tardif, Nadia Bouabdallaoui, et al.
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 5, pp. 776-785
Closed Access | Times Cited: 100
Michelle Samuel, Jean‐Claude Tardif, Nadia Bouabdallaoui, et al.
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 5, pp. 776-785
Closed Access | Times Cited: 100
Update on the Role of Colchicine in Cardiovascular Disease
Darcy Banco, Mohammad Hashim Mustehsan, Binita Shah
Current Cardiology Reports (2024) Vol. 26, Iss. 4, pp. 191-198
Closed Access | Times Cited: 9
Darcy Banco, Mohammad Hashim Mustehsan, Binita Shah
Current Cardiology Reports (2024) Vol. 26, Iss. 4, pp. 191-198
Closed Access | Times Cited: 9
Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies
Mariano Andrés
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 152-166
Open Access | Times Cited: 13
Mariano Andrés
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 152-166
Open Access | Times Cited: 13
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
Giovanni Cimmino, Francesco S. Loffredo, Gennaro De Rosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2483-2483
Open Access | Times Cited: 12
Giovanni Cimmino, Francesco S. Loffredo, Gennaro De Rosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2483-2483
Open Access | Times Cited: 12
Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation
Robert Zhang, Brittany Weber, Diego Araiza‐Garaygordobil, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 5, pp. 423-434
Closed Access | Times Cited: 4
Robert Zhang, Brittany Weber, Diego Araiza‐Garaygordobil, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 5, pp. 423-434
Closed Access | Times Cited: 4
Colchicine for the primary prevention of cardiovascular events
Arturo J Martí-Carvajal, Mario A Gemmato-Valecillos, Diana Monge Martín, et al.
Cochrane library (2025) Vol. 2025, Iss. 2
Open Access
Arturo J Martí-Carvajal, Mario A Gemmato-Valecillos, Diana Monge Martín, et al.
Cochrane library (2025) Vol. 2025, Iss. 2
Open Access
Inflammation as a Mechanism and Therapeutic Target in Peripheral Artery Disease
Noel Chan, Ke Xu, Tim A.C. de Vries, et al.
Canadian Journal of Cardiology (2022) Vol. 38, Iss. 5, pp. 588-600
Closed Access | Times Cited: 13
Noel Chan, Ke Xu, Tim A.C. de Vries, et al.
Canadian Journal of Cardiology (2022) Vol. 38, Iss. 5, pp. 588-600
Closed Access | Times Cited: 13
Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink
Edward Roddy, Ram Bajpai, Harry Forrester, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1618-1625
Open Access | Times Cited: 8
Edward Roddy, Ram Bajpai, Harry Forrester, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1618-1625
Open Access | Times Cited: 8
Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study
Michael Toprover, Binita Shah, Cheongeun Oh, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Michael Toprover, Binita Shah, Cheongeun Oh, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Low-Dose Colchicine in Coronary Artery Disease ― Systematic Review and Meta-Analysis ―
A Abrantes, Beatriz Nogueira-Garcia, Mariana Alves, et al.
Circulation Reports (2021) Vol. 3, Iss. 8, pp. 457-464
Open Access | Times Cited: 14
A Abrantes, Beatriz Nogueira-Garcia, Mariana Alves, et al.
Circulation Reports (2021) Vol. 3, Iss. 8, pp. 457-464
Open Access | Times Cited: 14
Risk of coronary artery disease in patients with gout on treatment with Colchicine: A systematic review and meta-analysis
Muhammad Umer Siddiqui, Joey Junarta, Swaminathan Sathyanarayanan, et al.
IJC Heart & Vasculature (2023) Vol. 45, pp. 101191-101191
Open Access | Times Cited: 4
Muhammad Umer Siddiqui, Joey Junarta, Swaminathan Sathyanarayanan, et al.
IJC Heart & Vasculature (2023) Vol. 45, pp. 101191-101191
Open Access | Times Cited: 4
Colchicine: Repositioning an “ancient” medicine in the 21st century
Е. Л. Насонов, О. М. Драпкина
Rheumatology Science and Practice (2024) Vol. 62, Iss. 5, pp. 445-464
Open Access | Times Cited: 1
Е. Л. Насонов, О. М. Драпкина
Rheumatology Science and Practice (2024) Vol. 62, Iss. 5, pp. 445-464
Open Access | Times Cited: 1
Colchicine Use and Major Adverse Cardiovascular Events in Male Patients with Gout and Established Coronary Artery Disease: A Veterans Affairs Nested Retrospective Cohort Study
Gary Ho, Michael Toprover, Daria B. Crittenden, et al.
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 1, pp. 11-24
Open Access | Times Cited: 3
Gary Ho, Michael Toprover, Daria B. Crittenden, et al.
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 1, pp. 11-24
Open Access | Times Cited: 3
Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
Michelle Samuel, David D. Waters
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 11, pp. 1697-1699
Open Access | Times Cited: 6
Michelle Samuel, David D. Waters
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 11, pp. 1697-1699
Open Access | Times Cited: 6
Efficacy and Safety of Colchicine in Prevention of Secondary Cardiovascular Outcomes Among Patients With Coronary Vessel Disease: A Meta-Analysis
Lubna Sattar, Rahat A Memon, Fatima Ashfaq, et al.
Cureus (2022)
Open Access | Times Cited: 4
Lubna Sattar, Rahat A Memon, Fatima Ashfaq, et al.
Cureus (2022)
Open Access | Times Cited: 4
Circulating circ_0069094 is Correlated with the Present and Endothelial Injury of Acute Coronary Syndrome
Zhen Gao, Peng Wu, Hezhong Zhu, et al.
Journal of Cardiovascular Translational Research (2024)
Closed Access
Zhen Gao, Peng Wu, Hezhong Zhu, et al.
Journal of Cardiovascular Translational Research (2024)
Closed Access
Managing Gout in Patients with Metabolic Syndrome
Esther Ebstein, Sèbastien Ottaviani
Drugs & Aging (2024) Vol. 41, Iss. 8, pp. 653-663
Closed Access
Esther Ebstein, Sèbastien Ottaviani
Drugs & Aging (2024) Vol. 41, Iss. 8, pp. 653-663
Closed Access
Colchicine linked with risk reduction for myocardial infarction in gout patients: systematic review and meta-analysis
Huipeng Wan, Linhong Zeng, Ruihai Xiao, et al.
Zeitschrift für Rheumatologie (2022) Vol. 81, Iss. 6, pp. 501-506
Closed Access | Times Cited: 2
Huipeng Wan, Linhong Zeng, Ruihai Xiao, et al.
Zeitschrift für Rheumatologie (2022) Vol. 81, Iss. 6, pp. 501-506
Closed Access | Times Cited: 2
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis: Lessons for Cholesterol from the Land of Gout
Binita Shah, Gary Ho, Sonal Pruthi, et al.
Contemporary cardiology (2023), pp. 321-349
Closed Access
Binita Shah, Gary Ho, Sonal Pruthi, et al.
Contemporary cardiology (2023), pp. 321-349
Closed Access
Inflammatory hypothesis of atherogenesis: Will colchicine be added to the armamentarium in the prevention of coronary artery disease?
Bahadir Simsek, Buğra Han Egeli, Atakan Selte, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100057-100057
Open Access
Bahadir Simsek, Buğra Han Egeli, Atakan Selte, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100057-100057
Open Access
